Sep 30 2024 |
FDA Public Meetings on Post-Market Assessment of Chemicals in Food |
Keller and Heckman LLP |
Sep 30 2024 |
Supply Agreements are Critical for Risk Mitigation in Food Manufacturing: Wisconsin’s Economic Loss Doctrine Bars Food Manufacturer’s Tort Claims for Contaminated Ingredients |
Foley & Lardner LLP |
Sep 30 2024 |
Telecom Alert: October 17th Meeting Agenda; $6 Million for Robocall Violations; NG911 Rules Compliance Date; State BEAD Approvals [Volume XXI, Issue 40] |
Keller and Heckman LLP |
Sep 30 2024 |
Missouri Cannabis Regulators Show Me a Well-Considered Clarification of Earlier Rule Essentially Banning Hemp Products |
Bradley Arant Boult Cummings LLP |
Sep 30 2024 |
Decentralized Clinical Trials: Research Misconduct Risks & How to Avoid Them |
Foley & Lardner LLP |
Sep 30 2024 |
Has California Just Declared A Fish To Be "Official State Crustacean"? |
Allen Matkins Leck Gamble Mallory & Natsis LLP |
Sep 27 2024 |
Final NIOSH Science Post in Series Celebrating NTRC Focuses on Measuring Nanomaterials |
Bergeson & Campbell, P.C. |
Sep 27 2024 |
McDermott+ Check-Up: September 27, 2024 |
McDermott Will & Emery |
Sep 27 2024 |
Hackers Attack Water Treatment Plant in Arkansas City Prompting Federal Investigation |
Katten |
Sep 27 2024 |
Overview of Food-Contact Material Regulations in Europe - Plastics |
K&L Gates LLP |
Sep 26 2024 |
Contract Manufacturing Versus an Alternating Proprietorship: What Is the Difference? |
McDermott Will & Emery |
Sep 26 2024 |
FDA Updates Mycotoxins in Domestic and Imported Human Foods Compliance Program |
Keller and Heckman LLP |
Sep 26 2024 |
Oh, My Hemp! The Legality of Intoxicating Hemp Products and the Problems with New Jersey’s New Hemp Law |
Stark & Stark |
Sep 26 2024 |
EPA Releases Draft Risk Evaluation for DINP for Public Comment |
Bergeson & Campbell, P.C. |
Sep 26 2024 |
Fourth Circuit Issues Opinion Regarding Hemp-Derived (Delta-9) Products in Case Involving ADA Claims |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Sep 26 2024 |
Mississippi Attorney General Deems Hemp Beverages Impermissible in Controversial Opinion, Highlighting Ongoing Tension Between the Marijuana and Hemp Industries |
Bradley Arant Boult Cummings LLP |
Sep 26 2024 |
Investigation of AI Training by Australian Radiology Provider Provides Important Reminder for U.S. Healthcare Providers |
Jackson Lewis P.C. |
Sep 26 2024 |
BIOSECURE Act: US to Target Chinese Biotechnology Companies |
McDermott Will & Emery |
Sep 25 2024 |
Congress Intensifies Tampon Safety Efforts and FDA Takes Steps to Respond |
Mintz |
Sep 25 2024 |
Health Canada Solicits Comments on Plant-Based Egg Alternative Labeling Guidance |
Keller and Heckman LLP |
Sep 25 2024 |
This Week in 340B: September 17 – 23, 2024 |
McDermott Will & Emery |
Sep 24 2024 |
EPA Proposes Updates to Recommendations of Specifications, Standards, and Ecolabels for Federal Purchasing |
Bergeson & Campbell, P.C. |
Sep 24 2024 |
FDA Issues Revised Guidance on the Control of Nitrosamine Impurities in Human Drugs |
Keller and Heckman LLP |
Sep 24 2024 |
FDA Updates Produce Safety Rule Small Entity Compliance Guide |
Keller and Heckman LLP |
Sep 24 2024 |
A Primer on Expungement, Pardons, and Sealing Criminal Records in Pennsylvania |
Norris McLaughlin P.A. |
Sep 24 2024 |
Senate Proposal Would Weed Out Prior Marijuana Use for Federal Job Applicants |
Bradley Arant Boult Cummings LLP |
Sep 20 2024 |
From Fentanyl to Freon: Customs and Border Protection Seizures |
Jackson Lewis P.C. |
Sep 19 2024 |
EC Adopts REACH Restriction for PFHxA and Related Substances |
Bergeson & Campbell, P.C. |
Sep 19 2024 |
Alabama CON Report - September 2024 |
Bradley Arant Boult Cummings LLP |
Sep 19 2024 |
Landmark Mental Health Parity Final Rule: What Plan Sponsors and Insurers Need to Know |
McDermott Will & Emery |
Sep 19 2024 |
FDA Release Results of Sampling of Retail Dairy-Free Dark Chocolate and Chocolate-Containing Products for Milk Allergen |
Keller and Heckman LLP |
Sep 19 2024 |
U.S. Youth Vaping Rates Continue to Show Dramatic Decline |
Keller and Heckman LLP |
Sep 19 2024 |
DEA Announces Marijuana Rescheduling Hearing Following Elections and the Stakes Are Hugely Consequential |
Bradley Arant Boult Cummings LLP |
Sep 19 2024 |
This Week in 340B: September 10 – 16, 2024 |
McDermott Will & Emery |
Sep 18 2024 |
Blank Rome State of the Cannabis Industry Panelist Interview Series: James Daley, Needham Bank Senior Vice President and Director Structured Finance |
Blank Rome LLP |